Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ran GAP1 Inhibitors

RAN GAP1 inhibitors belong to a specific chemical class of compounds designed to selectively target and modulate the activity of RAN GAP1 (Ran GTPase-activating protein 1). RAN GAP1 is a crucial regulatory protein involved in the cellular process known as the RAN GTPase cycle. This cycle plays a fundamental role in nucleocytoplasmic transport, a process by which molecules are transported between the cell nucleus and the cytoplasm. Nucleocytoplasmic transport is essential for various cellular functions, including the regulation of gene expression, cell cycle progression, and signal transduction. The chemical structures of RAN GAP1 inhibitors possess distinct molecular features that enable them to interact with RAN GAP1 in a specific manner. By doing so, these inhibitors interfere with the normal function of RAN GAP1, ultimately influencing the RAN GTPase cycle and nucleocytoplasmic transport. Inhibition of RAN GAP1 activity may lead to alterations in the transport of proteins and RNA molecules between the nucleus and cytoplasm, affecting cellular homeostasis and critical biological processes. The discovery and development of RAN GAP1 inhibitors involve extensive research and optimization of their chemical properties.

Medicinal chemists perform structure-activity relationship studies to enhance the binding affinity and selectivity of these inhibitors to RAN GAP1. Additionally, advancements in computational chemistry and high-throughput screening have expedited the identification of novel RAN GAP1 inhibitors with improved potency and pharmacological characteristics. Researchers are interested in RAN GAP1 inhibitors due to their implications in basic cellular biology and as valuable tools for investigating nucleocytoplasmic transport. By selectively inhibiting RAN GAP1, scientists aim to dissect the molecular mechanisms underlying nucleocytoplasmic transport and its impact on cellular function. The study of RAN GAP1 inhibitors can offer valuable insights into the regulation of intracellular transport processes and provide a better understanding of cellular organization and communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Fluorouracil inhibits the transcription factor ATF5 and has been studied for its potential in various diseases.

NFκB Activation Inhibitor II, JSH-23

749886-87-1sc-222061
sc-222061C
sc-222061A
sc-222061B
5 mg
10 mg
50 mg
100 mg
$210.00
$252.00
$1740.00
$1964.00
34
(1)

4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine is a synthetic compound known to selectively inhibit ATF2 activity and has been studied for its potential anti-inflammatory effects.

TOFA (5-(Tetradecyloxy)-2-furoic acid)

54857-86-2sc-200653
sc-200653A
10 mg
50 mg
$95.00
$367.00
15
(1)

TOFA (Trioxsalen with 8-methoxypsoralen) has been studied as an inhibitor of ATF2 and ATF4, showing potential in cancer research.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

A natural flavonoid found in many fruits and vegetables, quercetin has been investigated for its ability to inhibit ATF1 and ATF4.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid and its derivatives can inhibit the transcriptional activity of ATF1, ATF2, and ATF3.